Literature DB >> 9358573

Prenatal diagnosis of trisomy 9: cytogenetic, fish, and DNA studies.

C Van den Berg1, S K Ramlakhan, D Van Opstal, H Brandenburg, D J Halley, F J Los.   

Abstract

A cytogenetic survey and follow-up studies were performed in eight cases of full, mosaic, and pseudomosaic trisomy 9 prenatally diagnosed among 36,213 prenatal samples in our department between August 1970 and July 1996. Besides conventional chromosome analysis, interphase fluorescent in situ hybridization (FISH) was employed. FISH turned out to be a rapid and accurate method for verification of trisomy cell lines and could provide additional information to the prenatal cytogenetic results. FISH also enables the study of uncultured specimens of amniotic fluid, not accessible for traditional cytogenetic analysis. In three cases, retrospective DNA analysis showed the supernumerary chromosome 9 to be of maternal origin. The disomic cell lines in both mosaic trisomy 9 cases showed maternal uniparental disomy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9358573     DOI: 10.1002/(sici)1097-0223(199710)17:10<933::aid-pd179>3.3.co;2-s

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  3 in total

Review 1.  Confined placental mosaicism and intrauterine fetal growth.

Authors:  V S Lestou; D K Kalousek
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-11       Impact factor: 5.747

2.  Trisomy 9 mosaicism diagnosed in utero.

Authors:  Hironori Takahashi; Satoshi Hayashi; Yumiko Miura; Keiko Tsukamoto; Rika Kosaki; Yushi Itoh; Haruhiko Sago
Journal:  Obstet Gynecol Int       Date:  2010-07-25

Review 3.  Trisomy 9 mosaic syndrome: Sixteen additional patients with new and/or less commonly reported features, literature review, and suggested clinical guidelines.

Authors:  Mindy Li; Jennifer Glass; Xiaoli Du; Holly Dubbs; Margaret Horton Harr; Marni Falk; Teresa Smolarek; Robert J Hopkin; Elaine Zackai; Sarah E Sheppard
Journal:  Am J Med Genet A       Date:  2021-05-10       Impact factor: 2.578

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.